Deutsche Bank
MNPR icon

Deutsche Bank’s Monopar Therapeutics MNPR Stock Holding History

Deutsche Bank’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87M Buy
31,008
+2,186
+8% +$135K ﹤0.01% 1702
2026
Q1 		$1.58M Buy
28,822
+25,449
+754% +$1.54M ﹤0.01% 1915
2025
Q4 		$220K Sell
3,373
-639
-16% -$52.2K ﹤0.01% 2972
2025
Q3 		$328K Buy
4,012
+627
+19% +$28K ﹤0.01% 2785
2025
Q2 		$121K Buy
+3,385
New +$123K ﹤0.01% 3183

Other funds holding MNPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
GL
Gerber LLC Columbus, Ohio $213M AUM 25.63% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
MIM
Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Deutsche Bank's MNPR Position: Q2 2026 in Review

Deutsche Bank increased its Monopar Therapeutics (MNPR) stake by 7.6% in Q2 2026, buying an estimated $135K and bringing the position to 31,008 shares worth $2.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1702.

Deutsche Bank first reported a position in MNPR in Q2 2025 and has held it in 5 quarters since. 19 funds tracked by Wall St. Rank hold MNPR as of Q2 2026.

  • Deutsche Bank held 31,008 shares of Monopar Therapeutics worth $2.87M as of Q2 2026.
  • Deutsche Bank bought 2,186 Monopar Therapeutics shares in Q2 2026, an estimated $135K.
  • Monopar Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1702 holding.
  • Deutsche Bank first reported a position in Monopar Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 19 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.